Absci to Report Business Updates and Third Quarter 2024 Financial and Operating Results on November 12, 2024
15 Octobre 2024 - 2:00PM
Absci Corporation (Nasdaq: ABSI), a data-first generative AI drug
creation company, today announced the company will report business
updates and financial and operating results for the third quarter
before market open on Tuesday, November 12, 2024.
Absci management will webcast a corresponding
conference call beginning at 8:00 a.m. Eastern Time / 5:00 a.m.
Pacific Time to discuss its business developments, financial and
operating results, and outlook.
Live audio of the webcast will be available on
the company’s investor relations website at: investors.absci.com.
The webcast will be archived and available for replay after the
event.
About Absci
Absci is a data-first generative AI drug
creation company that combines AI with scalable wet lab
technologies to create better biologics for patients, faster. Our
Integrated Drug Creation™ platform unlocks the potential to
accelerate time to clinic and increase the probability of success
by simultaneously optimizing multiple drug characteristics
important to both development and therapeutic benefit. With the
data to train, the AI to create, and the wet lab to validate, we
can screen billions of cells per week, allowing us to go from
AI-designed candidates to wet lab-validated candidates in as little
as six weeks. Absci’s headquarters is in Vancouver, WA, with our AI
Research Lab in New York City and an Innovation Center in Zug,
Switzerland. Visit www.absci.com and follow us on LinkedIn
(@absci), X (Twitter) (@Abscibio), and YouTube.
Investor ContactAlex KhanVP,
Finance & Investor Relationsinvestors@absci.com
Media
Contactpress@absci.com
AbSci (NASDAQ:ABSI)
Graphique Historique de l'Action
De Nov 2024 à Déc 2024
AbSci (NASDAQ:ABSI)
Graphique Historique de l'Action
De Déc 2023 à Déc 2024